Generac Holdings (GNRC) Drops 10.76% on January 25

Equities Staff |

Generac Holdings (GNRC) was one of the Russell 2000's biggest losers for Monday January 25 as the stock slid 10.76% to $27.28, a loss of $-3.29 per share. Starting at an opening price of $30.00 a share, the stock traded between $27.16 and $30.15 over the course of the trading day. Volume was 1.1 million shares over 8,190 trades, against an average daily volume of 913,961 shares and a total float of 67.16 million.

The losses send Generac Holdings down to a market cap of $1.83 billion. In the last year, Generac Holdings has traded between $50.77 and $26.29, and its 50-day SMA is currently $29.94 and 200-day SMA is $34.27.

The stock has a P/E Ratio of 18.2.

Generac Holdings Inc is a designer and manufacturer of power generation equipment and other engine powered products serving the residential, light commercial, industrial and construction markets.

Generac Holdings is based out of Waukesha, WI and has some 3,587 employees. Its CEO is Aaron Jagdfeld.

For a complete fundamental analysis analysis of Generac Holdings, check out’s Stock Valuation Analysis report for GNRC. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…